Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis.
Antunes HS, Herchenhorn D, Small IA, Araújo CMM, Viégas CMP, de Assis Ramos G, Dias FL, Ferreira CG. Antunes HS, et al. Among authors: herchenhorn d. Oral Oncol. 2017 Aug;71:11-15. doi: 10.1016/j.oraloncology.2017.05.018. Epub 2017 Jun 3. Oral Oncol. 2017. PMID: 28688677 Clinical Trial.
XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy.
Pinho MB, Costas F, Sellos J, Dienstmann R, Andrade PB, Herchenhorn D, Peixoto FA, Santos VO, Small IA, Guimarães DP, Ferreira CG. Pinho MB, et al. Among authors: herchenhorn d. Urol Oncol. 2009 Jul-Aug;27(4):382-90. doi: 10.1016/j.urolonc.2008.03.016. Epub 2008 Jun 16. Urol Oncol. 2009. PMID: 18555708 Clinical Trial.
Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer.
Nogueira-Rodrigues A, do Carmo CC, Viegas C, Erlich F, Camisão C, Fontão K, Lima R, Herchenhorn D, Martins RG, Moralez GM, Small IA, Ferreira CG. Nogueira-Rodrigues A, et al. Among authors: herchenhorn d. Clin Cancer Res. 2008 Oct 1;14(19):6324-9. doi: 10.1158/1078-0432.CCR-07-5112. Clin Cancer Res. 2008. PMID: 18829516 Clinical Trial.
Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
Herchenhorn D, Dias FL, Viegas CM, Federico MH, Araújo CM, Small I, Bezerra M, Fontão K, Knust RE, Ferreira CG, Martins RG. Herchenhorn D, et al. Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):696-702. doi: 10.1016/j.ijrobp.2009.08.079. Epub 2010 Apr 24. Int J Radiat Oncol Biol Phys. 2010. PMID: 20421154 Clinical Trial.
Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS, Herchenhorn D, Small IA, Araújo CM, Viégas CM, Cabral E, Rampini MP, Rodrigues PC, Silva TG, Ferreira EM, Dias FL, Ferreira CG. Antunes HS, et al. Among authors: herchenhorn d. Radiother Oncol. 2013 Nov;109(2):297-302. doi: 10.1016/j.radonc.2013.08.010. Epub 2013 Sep 14. Radiother Oncol. 2013. PMID: 24044799 Clinical Trial.
38 results